Biogen | BIIB - Interest Income


Biogen reported $31.6M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Acadia Pharmaceuticals USD 8.25M 1M Sep/2025
ALKERMES USD 11.94M 853K Sep/2025
Bayer EUR 130M 38M Sep/2025
Biogen USD 31.6M 700K Sep/2025
BioMarin Pharmaceutical USD 17.85M 973K Sep/2025
Eli Lilly USD 65M 25M Sep/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Gilead Sciences USD 95M 7M Dec/2025
Incyte USD 30.75M 3.97M Dec/2025
Merck USD 96M 27M Sep/2025
Moderna USD 73M 8M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sanofi EUR 33M 81M Dec/2025
Sanofi EUR 114M 38M Sep/2025
Sarepta Therapeutics USD 8.38M 1.24M Sep/2025
Ultragenyx Pharmaceutical USD 5.86M 69K Sep/2025
United Therapeutics USD 46.4M 4.9M Sep/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025